| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8219365 | International Journal of Radiation Oncology*Biology*Physics | 2014 | 9 Pages |
Abstract
This study met the primary endpoint by showing a rate of 4.1% grade 3 toxicity for neoadjuvant short-course proton-based chemoradiation. Treatment was associated with favorable local control. In exploratory analyses, KRASG12D status and high CXCR7 expression and circulating CEA, CA19-9, and HGF levels were associated with poor survival.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Theodore S. MD, David P. MD, Darrell R. PhD, Lawrence S. MD, Beow Y. ScD, Marek PhD, Vikram MD, Shweta MD, Jennifer Y. MD, Yves PhD, Raymond C. MD, Eunice L. MD, PhD, Jill N. MD, Jeffrey W. MD, Andrew X. MD, PhD, Cristina R. MD, Harvey J. MD, PhD,